New York Times: A top federal pandemic official warned last June that Emergent BioSolutions, the government contractor that last month threw out millions of doses of COVID-19 vaccines because of contamination, lacked enough trained staff and had a record of problems with quality control. A copy of the official’s assessment, obtained by the New York Times, cited “key risks” in relying on Emergent to handle the production of vaccines developed by both Johnson & Johnson and AstraZeneca at Emergent’s Bayview plant in Baltimore.